1-6 of 6
Jan J. Cornelissen
Close
Sort by
Journal Articles

Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study

Joshua A. Fein, Roni Shouval, Jacques-Emmanuel Galimard, Myriam Labopin, Gérard Socié, Jürgen Finke, Jan J. Cornelissen, Ram Malladi, Maija Itälä-Remes, Patrice Chevallier, Kim H. Orchard, Donald Bunjes, Mahmoud Aljurf, Marie Thérèse Rubio, Jurjen Versluis, Mohamad Mohty, Arnon Nagler
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2143–2152.
https://doi.org/10.1182/bloodadvances.2022008656
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe

Hanadi Rafii, Annalisa Ruggeri, Chantal Kenzey, Jaime Sanz, Régis Peffault De La Tour, Albert Esquirol, Gérard Michel, Patrice Chevallier, Marie-Thérèse Rubio, Jan J. Cornelissen, Mauricette Michallet, Fernanda Volt, Monica M. Rivera-Franco, Graziana Maria Scigliuolo, Barbara Cappelli, Vanderson Rocha, Eliane Gluckman
Journal: Blood Advances
Blood Adv (2023) 7 (10): 1976–1986.
https://doi.org/10.1182/bloodadvances.2022007941
Published: 2023
Journal Articles

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Clinical Trials & Observations
Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina, Mette D. Hazenberg, Marinus van Marwijk Kooy, Marco R. de Groot, Michel van Gelder, Jürgen Kuball, Bronno van der Holt, Ellen Meijer, Jan J. Cornelissen,
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3378–3385.
https://doi.org/10.1182/bloodadvances.2021005847
Published: 2022
Includes: Supplemental data
Journal Articles

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

Clinical Trials & Observations
Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Constantijn J. M. Halkes, Rob Fijnheer, Violaine Havelange, Geerte L. van Sluis, Marie-Cecile Legdeur, Dries Deeren, Alain Gadisseur, Harm A. M. Sinnige, Dimitri A. Breems, Aurélie Jaspers, Ollivier Legrand, Wim E. Terpstra, Rinske S. Boersma, Dominiek Mazure, Agnes Triffet, Lidwine W. Tick, Karolien Beel, Johan A. Maertens, H. Berna Beverloo, Marleen Bakkus, Christa H. E. Homburg, Valerie de Haas, Vincent H. J. van der Velden, Jan J. Cornelissen, the Dutch-Belgian HOVON Cooperative group
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1115–1125.
https://doi.org/10.1182/bloodadvances.2021005624
Published: 2022
Includes: Supplemental data
Journal Articles

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Clinical Trials & Observations
Burak Kalin, Yvette van Norden, Michel van Gelder, Dimitri Breems, Johan Maertens, Mojca Jongen-Lavrencic, Annoek E. C. Broers, Eric Braakman, Tim Grob, Wendelien Zeijlemaker, Gert J. Ossenkoppele, Ellen Meijer, Jan J. Cornelissen
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4430–4437.
https://doi.org/10.1182/bloodadvances.2020002074
Published: 2020
Includes: Supplemental data
Journal Articles

Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

Jurjen Versluis, Myriam Labopin, Annalisa Ruggeri, Gerard Socie, Depei Wu, Liisa Volin, Didier Blaise, Noel Milpied, Charles Craddock, Ibrahim Yakoub-Agha, Johan Maertens, Per Ljungman, Anne Huynh, Mauricette Michallet, Eric Deconinck, Patrice Chevallier, Jakob Passweg, Fabio Ciceri, Mohamad Mohty, Jan J. Cornelissen, Arnon Nagler
Journal: Blood Advances
Blood Adv (2017) 1 (7): 477–485.
https://doi.org/10.1182/bloodadvances.2016002386
Published: 2017
Includes: Supplemental data